Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials

Odile Launay, Xavier Duval, Serge Fitoussi, Wolfgang Jilg, Angkool Kerdpanich, May Montellano, Tino F Schwarz, Veerachai Watanveerade, Jürgen J Wenzel, Gerard Zalcman, Vinod Bambure, Ping Li, Adrian Caplanusi, Anuradha Madan, Paul Gillard, David W Vaughn

Open source

DOI: 10.1186/1471-2334-13-435
Published: 2013-09-16
Container: BMC Infectious Diseases
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/1471-2334-13-435,
  title = {Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials},
  author = {Odile Launay and Xavier Duval and Serge Fitoussi and Wolfgang Jilg and Angkool Kerdpanich and May Montellano and Tino F Schwarz and Veerachai Watanveerade and Jürgen J Wenzel and Gerard Zalcman and Vinod Bambure and Ping Li and Adrian Caplanusi and Anuradha Madan and Paul Gillard and David W Vaughn},
  year = {2013},
  journal = {BMC Infectious Diseases},
  doi = {10.1186/1471-2334-13-435},
  url = {https://doi.org/10.1186/1471-2334-13-435}
}

RIS

TY  - JOUR
TI  - Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials
AU  - Odile Launay
AU  - Xavier Duval
AU  - Serge Fitoussi
AU  - Wolfgang Jilg
AU  - Angkool Kerdpanich
AU  - May Montellano
AU  - Tino F Schwarz
AU  - Veerachai Watanveerade
AU  - Jürgen J Wenzel
AU  - Gerard Zalcman
AU  - Vinod Bambure
AU  - Ping Li
AU  - Adrian Caplanusi
AU  - Anuradha Madan
AU  - Paul Gillard
AU  - David W Vaughn
PY  - 2013
JO  - BMC Infectious Diseases
DO  - 10.1186/1471-2334-13-435
UR  - https://doi.org/10.1186/1471-2334-13-435
ER  -

APA

Launay, O., Duval, X., Fitoussi, S., Jilg, W., Kerdpanich, A., Montellano, M., Schwarz, T. F., Watanveerade, V., Wenzel, J. J., Zalcman, G., Bambure, V., Li, P., Caplanusi, A., Madan, A., Gillard, P., & Vaughn, D. W. (2013). Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials. BMC Infectious Diseases. https://doi.org/10.1186/1471-2334-13-435

Source records

crossref · retrieved 2026-09-26T11:16:20.779Z